Interim Analysis. An interim safety analysis will be performed after 5 patients have completed the Day 30 visit, on all data collected up to this timepoint.
Appears in 7 contracts
Sources: License and Commercialization Agreement (Bellerophon Therapeutics, Inc.), License and Commercialization Agreement (Bellerophon Therapeutics LLC), License and Commercialization Agreement (Bellerophon Therapeutics LLC)